No Data
No Data
嘉和生物-B:2023年度報告
Jiahe Bio-B issued 4.442,400 shares due to the exercise of share options
Jiahe Bio-B (06998) announced that on April 10, 2024, the company issued 4.442,400 shares due to director Guo Feng exercising share options under the pre-initial public offering share option plan.
As a result of the exercise of share options, Jiahe Bio-B (06998) issued 4.442,400 shares
According to Zhitong Finance App News, Jiahe Bio-B (06998) announced that on April 10, 2024, the company issued 4.442,400 shares due to director Guo Feng exercising share options under the pre-initial public offering share option plan.
Jiahe Bio-B (06998) issued 12,000 shares to exercise share options under the pre-initial public offering share option plan on April 2
Jiahe Biological-B (06998) issued an announcement on April 2, 2024 due to the initial disclosure of eligible employees...
Jiahe Bio-B (06998) announced 2023 results. Losses attributable to owners of about 674 million yuan narrowed 7.65% year-on-year
Jiahe Bio-B (06998) announced its 2023 results. The total revenue was zero, and the 2022 revenue was about 159...
GENOR-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023 AND PROPOSED ADOPTION OF THE EIGHTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
No Data